Depression is a common symptom that comes with patients suffering from lung cancer. During the journey from lung cancer diagnosis to its treatment, involves significant time and various treatment processes. Some patients…
Category: Lung Cancer News
US FDA Approves Roche’s Tecentriq as Adjuvant Treatment for Early NSCLC
The US Food and Drug Administration (FDA) has approved Roche’s Tecentriq or atezolizumab as adjuvant treatment for patients with Stage II-IIIA non-small cell lung cancer (NSCLC) whose tumors express PD-L1=1%, as determined…
Takeda’s Exkivity Approved by FDA for Rare form of Lung Cancer
Takeda Pharmaceutical Co. Ltd. becomes the first one to get FDA approval for an oral drug targeted against rare form of non-small cell lung cancer. FDA has approved Exkivity (mobocertinib) for treatment…
Indian Scientists Develop 3D Robotic Motion Phantom for Lung Cancer Treatment
Indian scientists have developed a novel three-dimensional robotic motion phantom that is capable of reproducing human lung motion. This robotic motion has been developed by Ashish Dutta, Professor at IIT Kanpur, Professor…
Researchers Find Potential Marker for Success in Immunotherapy in Lung Cancer Patients
Lung Cancer has the highest mortality rate of all cancer and smoking remains the main cause behind this deadly disease. As far as the treatment options for lung cancer are considered, there…
Study: Lung Cancer Patients Can Be Screened For MET Oncogene
The researchers at Mayo Clinic Cancer Center have conducted a research and their findings are published in Cancer Discovery, a journal of American Association for Cancer Research. Their research suggests that physicians…
Study Suggests, Not to Delay Lung Cancer Surgery
According to a new study by researchers at Washington University School of Medicine in St. Louis, delaying lung cancer surgery for more than 12 weeks from the date of diagnosis with CT…
FDA Approves Rybrevant for Certain Patients with Non-Small Cell Lung Cancer
Lung cancer is a complex disease, accounting for almost 25% of all cancer deaths. The Food and Drug Administration (FDA) has approved Rybrevant for treatment of adults with non-small cell lung cancer…